SCHEMBL16156845

SCHEMBL16156845

Cc1ccc2c(c1)c1cc(Br)ccc1n2CCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.63
▸ POLB P06746 1/20 0.63
▸ HSD17B10 Q99714 1/20 0.63
▸ L3MBTL1 Q9Y468 1/20 0.63
▸ FABP3 P05413 1/20 0.50
▸ FABP4 P15090 1/20 0.50
▸ FABP5 Q01469 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.47
▸ KMO O15229 2/20 0.44
▸ DNM1 Q05193 4/20 0.43
▸ TSPO P30536 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ PPARG P37231 1/20 0.42
▸ PPARA Q07869 1/20 0.42
▸ AKR1B1 P15121 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.42
▸ DNMT1 P26358 1/20 0.42
▸ TBXAS1 P24557 2/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16156848 0.91 KDM4E (0.73) KDM4EPOLBHSD17B10L3MBTL1FABP3
SCHEMBL13403413 0.91 FABP4 (0.59) KDM4EPOLBHSD17B10L3MBTL1FABP3
SCHEMBL15486750 0.85 PTGDR2 (0.53) KDM4EPOLBHSD17B10L3MBTL1TSPO
SCHEMBL27543262 0.84 FABP4 (0.73) KDM4EFABP3FABP4FABP5ALDH1A1
SCHEMBL17482066 0.84 FABP4 (0.73) KDM4EPOLBHSD17B10L3MBTL1FABP3
SCHEMBL16156844 0.83 KDM4E (0.63) KDM4EPOLBHSD17B10L3MBTL1FABP3
SCHEMBL17482011 0.83 KDM4E (0.63) KDM4EPOLBHSD17B10L3MBTL1FABP3
SCHEMBL14690032 0.82 DNM1 (0.47) KDM4EPOLBHSD17B10L3MBTL1ALDH1A1
SCHEMBL17482014 0.82 KDM4E (0.61) KDM4EPOLBHSD17B10L3MBTL1FABP3
SCHEMBL31305276 0.79 FABP4 (0.60) KDM4EPOLBHSD17B10L3MBTL1FABP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9862684-B2 Modulation of K2P channels THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-01-09 — — US disclosed
US-9862684-B2 Modulation of K2P channels THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-01-09 — — US disclosed
US-20160031814-A1 MODULATION OF K2P CHANNELS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-04 — — US disclosed
US-20160031814-A1 MODULATION OF K2P CHANNELS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-04 — — US disclosed
US-20160031814-A1 MODULATION OF K2P CHANNELS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-04 — — US disclosed
WO-2014165307-A9 MODULATION OF K2P CHANNELS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-11-27 — — WO disclosed
WO-2014165307-A2 MODULATION OF K2P CHANNELS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031814-A1 MODULATION OF K2P CHANNELS KCNJ2, KCNK2, KCNN3 KDM4E 1102/4885POLB 3655/4885HSD17B10 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback